NasdaqGS:RTIX

Stock Analysis Report

Executive Summary

RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide.

Snowflake

Fundamentals

Reasonable growth potential and fair value.

Risks

  • RTI Surgical Holdings has significant price volatility in the past 3 months.

Similar Companies

Share Price & News

How has RTI Surgical Holdings's share price performed over time and what events caused price changes?


Latest Share Price and Events


Market Performance


7 Day Return

-4.3%

NasdaqGS:RTIX

1.5%

US Medical Equipment

0.8%

US Market


1 Year Return

-27.8%

NasdaqGS:RTIX

9.7%

US Medical Equipment

1.9%

US Market

RTIX underperformed the Medical Equipment industry which returned 9.6% over the past year.

RTIX underperformed the Market in United States of America which returned 2.1% over the past year.


Share holder returns

RTIXIndustryMarket
7 Day-4.3%1.5%0.8%
30 Day-1.3%0.7%3.4%
90 Day-27.8%2.4%2.1%
1 Year-27.8%-27.8%10.6%9.7%4.2%1.9%
3 Year3.0%3.0%70.2%65.0%46.7%37.2%
5 Year-39.3%-39.3%136.0%109.1%62.3%44.5%

Price Volatility Vs. Market

How volatile is RTI Surgical Holdings's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is RTI Surgical Holdings undervalued based on future cash flows and its price relative to the stock market?

>50%

Discount to future cash flow value


Intrinsic Value Based on Future Cash Flows

RTI Surgical Holdings's share price is below the future cash flow value, and at a moderate discount (> 20%).

RTI Surgical Holdings's share price is below the future cash flow value, and at a substantial discount (> 40%).


Price Based on Earnings

RTI Surgical Holdings is loss making, we can't compare its value to the US Medical Equipment industry average.

RTI Surgical Holdings is loss making, we can't compare the value of its earnings to the United States of America market.


Price Based on Expected Growth

Unable to calculate PEG ratio for RTI Surgical Holdings, we can't assess if its growth is good value.


Price Based on Value of Assets

RTI Surgical Holdings is good value based on assets compared to the US Medical Equipment industry average.


Next Steps

Future Growth

How is RTI Surgical Holdings expected to perform in the next 1 to 3 years based on estimates from 4 analysts?

121.6%

Forecasted annual earnings growth


Earnings and Revenue Growth Estimates


Future Annual Growth Analysis

RTI Surgical Holdings's revenue is expected to grow by 9.4% yearly, however this is not considered high growth (20% yearly).

RTI Surgical Holdings's earnings are expected to grow significantly at over 20% yearly.

RTI Surgical Holdings's revenue growth is expected to exceed the United States of America market average.

RTI Surgical Holdings's earnings growth is expected to exceed the United States of America market average.

RTI Surgical Holdings's earnings growth is expected to exceed the low risk savings rate of 2.7%.


Earnings per Share Growth Estimates


Future Return on Equity

RTI Surgical Holdings is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).


Next Steps

Past Performance

How has RTI Surgical Holdings performed over the past 5 years?

-13.8%

Historical annual earnings growth


Earnings and Revenue History


Past Earnings Growth Analysis

RTI Surgical Holdings does not make a profit and their year on year earnings growth rate was negative over the past 5 years.

Unable to compare RTI Surgical Holdings's 1-year earnings growth to the 5-year average as it is not currently profitable.

Unable to compare RTI Surgical Holdings's 1-year growth to the US Medical Equipment industry average as it is not currently profitable.


Return on Equity

It is difficult to establish if RTI Surgical Holdings has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.


Return on Assets

RTI Surgical Holdings used its assets less efficiently than the US Medical Equipment industry average last year based on Return on Assets.


Return on Capital Employed

It is difficult to establish if RTI Surgical Holdings improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.


Next Steps

Financial Health

How is RTI Surgical Holdings's financial position?


Financial Position Analysis

RTI Surgical Holdings is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.

RTI Surgical Holdings's long term commitments exceed its cash and other short term assets.


Debt to Equity History and Analysis

RTI Surgical Holdings's level of debt (54.1%) compared to net worth is high (greater than 40%).

The level of debt compared to net worth has increased over the past 5 years (34.3% vs 54.1% today).


Balance Sheet

High level of physical assets or inventory.

Debt is covered by short term assets, assets are 1.2x debt.


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

RTI Surgical Holdings has less than a year of cash runway based on current free cash flow.

Unable to confirm if RTI Surgical Holdings has at least 1 year of cash runway based on growing free cash flows without relevant data.


Next Steps

Dividend

What is RTI Surgical Holdings's current dividend yield, its reliability and sustainability?


Dividend Yield and Payments Analysis

Unable to evaluate RTI Surgical Holdings's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.

Unable to evaluate RTI Surgical Holdings's dividend against the top 25% market benchmark as the company has not reported any payouts.

Unable to perform a dividend volatility check as RTI Surgical Holdings has not reported any payouts.

Unable to verify if RTI Surgical Holdings's dividend has been increasing as the company has not reported any payouts.


Current Payout to Shareholders

Unable to calculate sustainability of dividends as RTI Surgical Holdings has not reported any payouts.


Future Payout to Shareholders

Insufficient estimate data to determine if a dividend will be paid in 3 years and that it will be sustainable.


Next Steps

Management

What is the CEO of RTI Surgical Holdings's salary, the management and board of directors tenure and is there insider trading?

2.3yrs

Average management tenure


CEO

Camille Farhat (49yo)

2.5yrs

Tenure

US$1,219,629

Compensation

Mr. Camille I. Farhat has been the Chief Executive Officer, President and Director at RTI Surgical, Inc. since March 15, 2017. Mr. Farhat served as the Chief Executive Officer of American Medical Systems,  ...


CEO Compensation Analysis

Camille's remuneration is about average for companies of similar size in United States of America.

Camille's compensation has been consistent with company performance over the past year, both up more than 20%.


Management Age and Tenure

2.3yrs

Average Tenure

50.5yo

Average Age

The tenure for the RTI Surgical Holdings management team is about average.


Board Age and Tenure

3.3yrs

Average Tenure

62yo

Average Age

The tenure for the RTI Surgical Holdings board of directors is about average.


Insider Trading

No 3 month open market individual insider trading information.


Recent Insider Transactions

SellUS$456,09718 Mar 19
PS Spine Holdco, LLC
EntityCompany
Shares79,505
Max PriceUS$5.82
BuyUS$214,00013 Dec 18
Jonathon Singer
EntityIndividual
Role
Chief Financial Officer
Chief Financial & Administrative Officer and Corporate Secretary
Shares50,000
Max PriceUS$4.28
BuyUS$44,33711 Dec 18
Camille Farhat
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares11,516
Max PriceUS$3.85
BuyUS$69,42710 Dec 18
Camille Farhat
EntityIndividual
Role
Chief Executive Officer
CEO, President & Director
Shares17,185
Max PriceUS$4.04

Ownership Breakdown


Management Team

  • Jonathon Singer (55yo)

    Chief Financial & Administrative Officer and Corporate Secretary

    • Tenure: 2yrs
    • Compensation: US$2.19m
  • Camille Farhat (49yo)

    CEO, President & Director

    • Tenure: 2.5yrs
    • Compensation: US$1.22m
  • John Varela (52yo)

    Executive Vice President of Global Operations

    • Tenure: 2.7yrs
    • Compensation: US$669.36k
  • Paul Montague

    Vice President of Human Resources

    • Tenure: 2.3yrs
  • Ryan Bartolucci (37yo)

    VP of Finance & Corporate Controller

    • Tenure: 1yrs
  • Molly Poarch

    Director of Corporate Communications

    • Tenure: 0yrs

Board Members

  • Paul Thomas (63yo)

    Independent Director

    • Tenure: 3.3yrs
    • Compensation: US$128.13k
  • Jeff Lightcap (60yo)

    Director

    • Tenure: 0.5yrs
  • Mark Stolper (48yo)

    Independent Director

    • Tenure: 2.5yrs
    • Compensation: US$132.50k
  • Curt Selquist (74yo)

    Chairman

    • Tenure: 3.6yrs
    • Compensation: US$175.00k
  • Chris Sweeney (44yo)

    Independent Director

    • Tenure: 3.9yrs
    • Compensation: US$115.00k
  • Nick Valeriani (62yo)

    Independent Director

    • Tenure: 3.3yrs
    • Compensation: US$127.50k
  • Tom McEachin (66yo)

    Independent Director

    • Tenure: 3.8yrs
    • Compensation: US$135.00k
  • Shirley Weis (65yo)

    Independent Director

    • Tenure: 4.9yrs
    • Compensation: US$142.91k
  • Camille Farhat (49yo)

    CEO, President & Director

    • Tenure: 2.5yrs
    • Compensation: US$1.22m

Company Information

RTI Surgical Holdings, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: RTI Surgical Holdings, Inc.
  • Ticker: RTIX
  • Exchange: NasdaqGS
  • Founded: 1997
  • Industry: Health Care Supplies
  • Sector: Healthcare
  • Market Cap: US$232.040m
  • Shares outstanding: 73.90m
  • Website: https://www.rtix.com

Number of Employees


Location

  • RTI Surgical Holdings, Inc.
  • 520 Lake Cook Road
  • Suite 315
  • Deerfield
  • Illinois
  • 60015
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
RTIXNasdaqGS (Nasdaq Global Select)YesCommon StockUSUSDAug 2000
RT2DB (Deutsche Boerse AG)YesCommon StockDEEURAug 2000

Biography

RTI Surgical Holdings, Inc., a surgical implant company, designs, develops, manufactures, and distributes biologic, metal, and synthetic implants worldwide. It processes donated human musculoskeletal and o ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2019/09/18 00:04
End of Day Share Price2019/09/17 00:00
Earnings2019/06/30
Annual Earnings2018/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.